Having held a variety of senior business development roles in leading contract development and manufacturing organisations throughout his 25-year career in the pharmaceutical and biotechnology industry, Martin brings extensive market insight and industry knowledge to TrakCel.
Prior to joining the company, Martin was Director of European Business Development for Catalent Pharma Services – one of the world’s largest contract development and manufacturing organisations. During his time as Vice President of Global Business Development at the Almac Group, Martin helped the group’s clinical trial supply business grow from a niche service offering to a major business with over 1,500 staff internationally. The skills and experience Martin brings to the team will be invaluable to the success of TrakCel moving forwards.
With over 12 years of experience working in the advanced therapy and regenerative medicine sectors of the biotechnology industry, Robert brings a wealth of expertise and experience to the TrakCel team. Before joining TrakCel, Robert was Vice President of Corporate Development for Cognate BioServices, where his efforts enabled the company to evolve into one of the leading commercial-scale cell therapy contract manufacturing organisations. Robert has also previously held positions of Senior Consultant and Vice President of Communications for the Alliance for Regenerative Medicine, and has been responsible for organising the World Stem Cell Summits. Robert’s deep understanding of the industry and cell therapy manufacturing will help to ensure TrakCel continues to be positioned as an industry leader.
“We are delighted to welcome Martin Lamb and Robert Margolin to the TrakCel team,” said Ravi Nalliah, Chief Executive Officer. “The extensive industry knowledge and years of experience Robert and Martin have perfectly extends that of the company. This is an exciting time for TrakCel and we are looking forward to seeing what the future brings.”
